MIRO
NASDAQMiromatrix Medical Inc.
$3.40+0.03 (+0.89%)
News25/Ratings1
Latest news
25 items- 13D/GSEC Form SC 13G/A filed by Miromatrix Medical Inc. (Amendment)SC 13G/A - Miromatrix Medical Inc. (0001527096) (Subject)
- 13D/GSEC Form SC 13G/A filed by Miromatrix Medical Inc. (Amendment)SC 13G/A - Miromatrix Medical Inc. (0001527096) (Subject)
- SECSEC Form 15-12G filed by Miromatrix Medical Inc.15-12G - Miromatrix Medical Inc. (0001527096) (Filer)
- 13D/GSEC Form SC 13D filed by Miromatrix Medical Inc.SC 13D - Miromatrix Medical Inc. (0001527096) (Subject)
- SECMiromatrix Medical Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update8-K - Miromatrix Medical Inc. (0001527096) (Filer)
- SECSEC Form EFFECT filed by Miromatrix Medical Inc.EFFECT - Miromatrix Medical Inc. (0001527096) (Filer)
- INSIDERNew insider United Therapeutics Corp claimed ownership of 27,419,228 shares (SEC Form 3)3 - Miromatrix Medical Inc. (0001527096) (Issuer)
- INSIDERHeine Lisa Wipperman returned 67,413 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Miromatrix Medical Inc. (0001527096) (Issuer)
- INSIDERMaag Peter returned 58,368 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Miromatrix Medical Inc. (0001527096) (Issuer)
- INSIDERErb John L returned 54,201 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Miromatrix Medical Inc. (0001527096) (Issuer)
- INSIDERBuckman Paul returned 54,201 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Miromatrix Medical Inc. (0001527096) (Issuer)
- INSIDERBurke William P. Mr. returned 67,413 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Miromatrix Medical Inc. (0001527096) (Issuer)
- INSIDERDouglas James Michael returned 20,000 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Miromatrix Medical Inc. (0001527096) (Issuer)
- INSIDERRoss Jeffrey James returned 87,500 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Miromatrix Medical Inc. (0001527096) (Issuer)
- SECSEC Form POS AM filed by Miromatrix Medical Inc.POS AM - Miromatrix Medical Inc. (0001527096) (Filer)
- SECSEC Form S-8 POS filed by Miromatrix Medical Inc.S-8 POS - Miromatrix Medical Inc. (0001527096) (Filer)
- SECSEC Form S-8 POS filed by Miromatrix Medical Inc.S-8 POS - Miromatrix Medical Inc. (0001527096) (Filer)
- SECSEC Form SC 14D9/A filed by Miromatrix Medical Inc. (Amendment)SC 14D9/A - Miromatrix Medical Inc. (0001527096) (Subject)
- SECSEC Form SC TO-T/A filed by Miromatrix Medical Inc. (Amendment)SC TO-T/A - Miromatrix Medical Inc. (0001527096) (Subject)
- PRUnited Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and MergerUnited Therapeutics Corporation (Nasdaq: UTHR) and Miromatrix Medical Inc. (Nasdaq: MIRO) announced today that United Therapeutics, through its wholly owned subsidiary Morpheus Subsidiary Inc. ("Merger Sub"), has successfully completed the previously announced tender offer to acquire all outstanding shares of Miromatrix for a purchase price of $3.25 per share in cash at closing and an additional $1.75 per share in cash upon the achievement of a clinical development milestone related to Miromatrix's development-stage, fully-implantable manufactured kidney product known as mirokidney™ by December 31, 2025. The tender offer expired at one minute after 11:59 p.m., New York City time, on Decem
- SECSEC Form 25-NSE filed by Miromatrix Medical Inc.25-NSE - Miromatrix Medical Inc. (0001527096) (Subject)
- 13D/GSEC Form SC 13G/A filed by Miromatrix Medical Inc. (Amendment)SC 13G/A - Miromatrix Medical Inc. (0001527096) (Subject)
- SECSEC Form SC 14D9/A filed by Miromatrix Medical Inc. (Amendment)SC 14D9/A - Miromatrix Medical Inc. (0001527096) (Subject)
- SECSEC Form SC TO-T/A filed by Miromatrix Medical Inc. (Amendment)SC TO-T/A - Miromatrix Medical Inc. (0001527096) (Subject)
- PRUnited Therapeutics and Miromatrix Medical Announce Successful Tender OfferUnited Therapeutics Corporation (Nasdaq: UTHR) and Miromatrix Medical Inc. (Nasdaq: MIRO) announced today the results of the previously announced tender offer by Morpheus Subsidiary Inc. ("Merger Sub"), a wholly owned subsidiary of United Therapeutics, to acquire all outstanding shares of Miromatrix for a purchase price of $3.25 per share in cash at closing and an additional $1.75 per share in cash upon the achievement of a clinical development milestone related to Miromatrix's development-stage, fully-implantable manufactured kidney product known as mirokidney™ by December 31, 2025. The tender offer expired at one minute after 11:59 p.m., New York City time, on December 11, 2023. Contine